OpenSPR-XT will accelerate discoveries in protein science by offering affordable & fully automated binding kinetics for life sciences researchers from academia to industry
Kitchener, ON, January 20, 2016: Nicoya Lifesciences, a leader in label-free molecular analysis, announced today its newest product, OpenSPR-XT – a fully automated molecular analysis instrument based on the highly successful OpenSPR instrument.
The release of OpenSPR-XT will provide life sciences researchers from academia to industry with a high throughput SPR solution that is affordable for every lab. The OpenSPR line of surface plasmon resonance instruments uses proprietary nanotechnology based sensors to provide high quality molecular interaction data at a fraction of the cost of traditional SPR instruments. By combining this technology with robust and user friendly automation, OpenSPR-XT saves time, reduces errors, and improves data quality and repeatability. This product provides critical data needed by life sciences researchers, such as binding kinetics, affinity, and specificity of proteins, antibodies, nucleic acids, small molecules and more.
Ryan Denomme, Nicoya’s CEO, said: “The launch of OpenSPR-XT addresses a major gap in the market. Most researchers could not afford to have a fully automated SPR solution in their own labs – they had to rely on costly outsourcing or using an inconvenient central lab facility. Now they can have a powerful, high throughput instrument in their own lab, which will help accelerate new discoveries in fields like biotherapeutics. This product is a result of the feedback we have received from our customers, and will allow us to meet the growing demand for high throughput molecular analysis while continuing to remain the most affordable solution on the market.”
The company officially launched OpenSPR-XT at Peptalk 2016: The Protein Science Week in San Diego. More information can be found at www.nicoyalife.com/opensprXT.
About Nicoya Lifesciences
Nicoya Lifesciences is a nanotechnology company developing sensor products that will change the world. It is committed to bringing high quality products with unique, innovative designs to market to solve some of the world’s most important problems. OpenSPR, Nicoya’s flagship product, is the world’s first personal SPR instrument. Using proprietary nanotechnology sensors, it provides powerful label-free molecular analysis in a compact, easy to use, and affordable package.
For more information contact:
Ryan Denomme, CEO Nicoya Lifesciences